Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Assessing lung recruitment in ARDS patients using electrical impedance tomography

Official title: RecruitmEnt Assessed by eleCtRical Impedance Tomography: Feasibility, Correlation With Clinical oUtcomes and pIloT Data on Personalised PEEP Selection.

Run by Unity Health Toronto · NCT04460859 · Data updated 2026-11-12

This study is testing if a new method using electrical signals can help doctors see how well the lungs of patients with ARDS can be opened up for better breathing while they are on a ventilator.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment171 (estimated)
SponsorUnity Health Toronto
Academic / other
Locations4 sites (São Paulo and 3 other locations)
StatusRecruiting
StartedJune 9, 2020
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedMay 20, 2025
Trial IDNCT04460859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are intubated patients diagnosed with moderate to severe ARDS, characterized by a PaO2/FiO2 ratio of 200 mmHg or less.

Probably not a fit

Patients who are under 18 years old, have hemodynamic instability, or have contraindications to EIT monitoring will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The RECRUIT study is a multinational observational study that aims to evaluate the feasibility of using electrical impedance tomography (EIT) to measure lung recruitment potential in patients with Acute Respiratory Distress Syndrome (ARDS) who are mechanically ventilated. This single-day study involves specific lung recruitment maneuvers to gather data on how well patients' lungs can be recruited for better oxygenation. By analyzing the responses to these maneuvers, the study seeks to develop personalized methods for optimizing positive end-expiratory pressure (PEEP) settings in real-time. The ultimate goal is to minimize risks associated with inadequate mechanical ventilation in ARDS patients.

Why it matters

Potential benefit: If successful, this study could lead to improved personalized ventilation strategies that enhance oxygenation and potentially increase survival rates in ARDS patients.

How similar studies have gone: While the use of EIT in this context is relatively novel, previous studies have shown promise in using similar techniques for assessing lung function and recruitment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intubated moderate and severe ARDS according to the Berlin definition (PaO2/FiO2 ratio \<= 200 mmHg)
* Under continuous sedation with or without paralysis

Exclusion Criteria:

* Age \<18 years
* Bronchopleural fistula
* Pure COPD exacerbation
* Contraindication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode belt placement)
* Hemodynamic instability (Systolic BP \< 75 mmHg or MAP \< 60 mmHg despite vasopressors and/or heart rate \< 55 bpm)
* Attending physician deems the transient application of high airway pressures to be unsafe

Where it's running

  • Faculdade de Medicina da University São Paulo
    São Paulo, Brazil
    Recruiting
  • St. Michael's Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Vall d'Hebron University Hospital
    Barcelona, Spain
    Recruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.